NEW YORK, Sept. 24 – Solexa, a UK-based developer of high-throughput technology, has closed on roughly $12 million in its second round of venture capital financing, the company said on Monday.

Nick McCooke, Solexa's president and managing director, told GenomeWeb that the cash will be used to help create “the next generation of DNA sequencing tools.” McCooke reckons this recent cash infusion should be enough help the company meet that goal, which he said would likely happen within two years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.